Neurological and (neuro)psychological sequelae in intensive care and general ward COVID-19 survivors
- PMID: 37010152
- DOI: 10.1111/ene.15812
Neurological and (neuro)psychological sequelae in intensive care and general ward COVID-19 survivors
Abstract
Background and purpose: Coronavirus disease 2019 (COVID-19) affects the brain, leading to long-term complaints. Studies combining brain abnormalities with objective and subjective consequences are lacking. Long-term structural brain abnormalities, neurological and (neuro)psychological consequences in COVID-19 patients admitted to the intensive care unit (ICU) or general ward were investigated. The aim was to create a multidisciplinary view on the impact of severe COVID-19 on functioning and to compare long-term consequences between ICU and general ward patients.
Methods: This multicentre prospective cohort study assessed brain abnormalities (3 T magnetic resonance imaging), cognitive dysfunction (neuropsychological test battery), neurological symptoms, cognitive complaints, emotional distress and wellbeing (self-report questionnaires) in ICU and general ward (non-ICU) survivors.
Results: In al, 101 ICU and 104 non-ICU patients participated 8-10 months post-hospital discharge. Significantly more ICU patients exhibited cerebral microbleeds (61% vs. 32%, p < 0.001) and had higher numbers of microbleeds (p < 0.001). No group differences were found in cognitive dysfunction, neurological symptoms, cognitive complaints, emotional distress or wellbeing. The number of microbleeds did not predict cognitive dysfunction. In the complete sample, cognitive screening suggested cognitive dysfunction in 41%, and standard neuropsychological testing showed cognitive dysfunction in 12%; 62% reported ≥3 cognitive complaints. Clinically relevant scores of depression, anxiety and post-traumatic stress were found in 15%, 19% and 12%, respectively; 28% experienced insomnia and 51% severe fatigue.
Conclusion: Coronavirus disease 2019 ICU survivors had a higher prevalence for microbleeds but not for cognitive dysfunction compared to general ward survivors. Self-reported symptoms exceeded cognitive dysfunction. Cognitive complaints, neurological symptoms and severe fatigue were frequently reported in both groups, fitting the post-COVID-19 syndrome.
Keywords: COVID-19; ICU; SARS-CoV-2; affective; brain damage; cognitive; neurological; neuropsychological.
© 2023 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.
Similar articles
-
A Biopsychosocial Approach to Persistent Post-COVID-19 Fatigue and Cognitive Complaints: Results of the Prospective Multicenter NeNeSCo Study.Arch Phys Med Rehabil. 2024 May;105(5):826-834. doi: 10.1016/j.apmr.2023.12.014. Epub 2024 Jan 14. Arch Phys Med Rehabil. 2024. PMID: 38228250
-
Objective and subjective cognition in survivors of COVID-19 one year after ICU discharge: the role of demographic, clinical, and emotional factors.Crit Care. 2023 May 15;27(1):188. doi: 10.1186/s13054-023-04478-7. Crit Care. 2023. PMID: 37189173 Free PMC article. Clinical Trial.
-
Depressive and Anxiety Symptoms in Severe COVID-19 Survivors: A Prospective Cohort Study.Psychiatr Q. 2022 Sep;93(3):891-903. doi: 10.1007/s11126-022-09998-z. Epub 2022 Aug 10. Psychiatr Q. 2022. PMID: 35947293 Free PMC article.
-
Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis.J Neurol Sci. 2022 Mar 15;434:120162. doi: 10.1016/j.jns.2022.120162. Epub 2022 Jan 29. J Neurol Sci. 2022. PMID: 35121209 Free PMC article. Review.
-
Post-traumatic stress disorder: A differential diagnostic consideration for COVID-19 survivors.Clin Neuropsychol. 2020 Oct-Nov;34(7-8):1498-1514. doi: 10.1080/13854046.2020.1811894. Epub 2020 Aug 26. Clin Neuropsychol. 2020. PMID: 32847484 Review.
Cited by
-
A Prospective Study on Neural Biomarkers in Patients with Long-COVID Symptoms.J Pers Med. 2024 Mar 16;14(3):313. doi: 10.3390/jpm14030313. J Pers Med. 2024. PMID: 38541055 Free PMC article.
-
Cerebral Microbleeds in Critically Ill Patients with Respiratory Failure or Sepsis: A Scoping Review.Neurocrit Care. 2024 Mar 20. doi: 10.1007/s12028-024-01961-z. Online ahead of print. Neurocrit Care. 2024. PMID: 38506971
-
Prevalence and trajectories of neuropsychological post-COVID-19 symptoms in initially hospitalized patients.J Rehabil Med. 2024 Mar 12;56:jrm25315. doi: 10.2340/jrm.v56.25315. J Rehabil Med. 2024. PMID: 38470168 Free PMC article.
-
Blood-brain barrier breakdown in COVID-19 ICU survivors: an MRI pilot study.NeuroImmune Pharm Ther. 2023 Nov 22;2(4):333-338. doi: 10.1515/nipt-2023-0018. eCollection 2023 Dec. NeuroImmune Pharm Ther. 2023. PMID: 38058998 Free PMC article.
-
Routine Brain MRI Findings on the Long-Term Effects of COVID-19: A Scoping Review.Diagnostics (Basel). 2023 Jul 30;13(15):2533. doi: 10.3390/diagnostics13152533. Diagnostics (Basel). 2023. PMID: 37568896 Free PMC article. Review.
References
REFERENCES
-
- Correia AO, Feitosa PWG, de Sousa Moreira JL, Nogueira SÁR, Fonseca RB, Nobre MEP. Neurological manifestations of COVID-19 and other coronaviruses: a systematic review. Neurol Psychiatry Brain Res. 2020;37:27-32. doi:10.1016/j.npbr.2020.05.008
-
- Kim PH, Kim M, Suh CH, et al. Neuroimaging findings in patients with COVID-19: a systematic review and meta-analysis. Korean J Radiol. 2021;22(11):1875-1885. doi:10.3348/kjr.2021.0127
-
- Heesakkers H, van der Hoeven JG, Corsten S, et al. Clinical outcomes among patients with 1-year survival following intensive care unit treatment for COVID-19. JAMA. 2022;327:559-565. doi:10.1001/jama.2022.0040
-
- Hopkins RO, Suchyta MR, Beene K, Jackson JC. Critical illness acquired brain injury: neuroimaging and implications for rehabilitation. Rehabil Psychol. 2016;61(2):151-164. doi:10.1037/rep0000088
-
- Pezzini A, Padovani A. Lifting the mask on neurological manifestations of COVID-19. Nat Rev Neurol. 2020;16(11):636-644. doi:10.1038/s41582-020-0398-3
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous